In this episode of That's Derm Good!, host Janelle Ball welcomes Dr. Kyle Landry, President and Co-Founder of Delavie Sciences, for a fascinating conversation about the future of skincare and the science of skin longevity. With a career that spans food science, biotechnology, and even working with NASA, Dr. Landry brings a unique perspective to an industry often driven more by marketing than evidence.

Dr. Landry shares his journey into skincare innovation and explains why the conversation is shifting away from traditional anti-aging claims toward a more meaningful focus on skin longevity. He discusses how understanding the biological processes of aging can help consumers make better choices about the products they use and the routines they follow.

Throughout the episode, Dr. Landry breaks down the importance of clinical trials, the role of science-backed ingredients, and why rigorous testing matters when evaluating skincare products. He also explores the growing body of research surrounding the skin microbiome and how maintaining a healthy balance can influence overall skin health and resilience.

Listeners will gain valuable insights into how to navigate today's crowded skincare marketplace, identify products supported by real scientific evidence, and understand the ingredients that may actually make a difference. Whether you're a skincare enthusiast, healthcare professional, or simply looking to build a smarter routine, this episode offers a refreshing look at what happens when science leads the conversation.

Tune in to learn how innovations inspired by cutting-edge research, are helping redefine what healthy skin can look like—not just today, but for years to come.

DISCLAIMER: This podcast is for informational purposes only and should not be considered medical or health advice. This podcast does not substitute medical treatment. Always consult a doctor or dermatologist regarding medical advice, diagnoses, or treatment.

That’s Derm Good! is proudly part of Authorized Health—bringing you expert-driven conversations at the intersection of dermatology, access, and innovation